OVOL1 Promotes Proliferation and Metastasis of Non‐Small Cell Lung Cancer by Regulating APOE ‐Mediated Cholesterol Metabolism
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70634 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Shoujie Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Surgery Laboratory, Xuzhou Medical University, Xuzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Cholesterol, Lung Neoplasms, Apolipoproteins E. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Project supported by the Affiliated Hospital of Xuzhou Medical University, the Social Development Projects of Key R&D Programs in Xuzhou city.
Abstract (Originalsprache)
Non‐small cell lung cancer (NSCLC) is a highly lethal malignant tumour characterised by its resistance to treatment, often due to metabolic reprogramming. Despite this, the underlying mechanisms by which aberrant cholesterol metabolism influences the development and progression of NSCLC remain unclear. In our study, we observed that OVOL1 is significantly upregulated in NSCLC and is correlated with a poor prognosis. Furthermore, our functional assays revealed that OVOL1 enhances the proliferation and metastasis of NSCLC cells both in vitro and in vivo. Mechanistically, OVOL1 was found to modulate cholesterol reprogramming and increase the expression of APOE, thereby intensifying cholesterol metabolism and facilitating cell migration and invasion. In conclusion, our findings suggest that OVOL1 acts as an oncogene in NSCLC, promoting tumour growth and metastasis through the enhancement of cholesterol metabolism. This underscores the potential of OVOL1 as a therapeutic target for the treatment of NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Thoracic Surgery Laboratory, Xuzhou Medical University, Xuzhou, Jiangsu, China.
- Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
- Editorial Office of International Journal of Anesthesiology and Resuscitation, Xuzhou Medical University, Xuzhou, Jiangsu, China.
- Department of Emergency Medicine, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
ORCID-Profile: Hao Zhang
Förderung
- the Project supported by the Affiliated Hospital of Xuzhou Medical University
- the Social Development Projects of Key R&D Programs in Xuzhou city
Zitieren
APA
Feng, S., Zhang, L., Sun, T., Xu, L., Quan, X., Zhao, G., & Zhang, H. (2025). OVOL1 Promotes Proliferation and Metastasis of Non‐Small Cell Lung Cancer by Regulating APOE ‐Mediated Cholesterol Metabolism. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70634
Vancouver
Feng S, Zhang L, Sun T, Xu L, Quan X, Zhao G, et al. OVOL1 Promotes Proliferation and Metastasis of Non‐Small Cell Lung Cancer by Regulating APOE ‐Mediated Cholesterol Metabolism. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70634
BibTeX
@article{Feng2025,
author = {Feng, Shoujie and Zhang, Li and Sun, Teng and Xu, Lei and Quan, Xiaoyu and Zhao, Guoqing and Zhang, Hao},
title = {OVOL1 Promotes Proliferation and Metastasis of Non‐Small Cell Lung Cancer by Regulating APOE ‐Mediated Cholesterol Metabolism},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70634}
}
EUVIMED